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Serum glucocorticoids play a critical role in synchronizing
circadian rhythm in peripheral tissues, and multiple mecha-
nisms regulate tissue sensitivity to glucocorticoids. In the skel-
eton, circadian rhythm helps coordinate bone formation and
resorption. Circadian rhythm is regulated through transcrip-
tional and post-transcriptional feedback loops that include
microRNAs . How microRNAs regulate circadian rhythm in
bone is unexplored. We show that in mouse calvaria, miR-433
displays robust circadian rhythm, peaking just after dark. In
C3H/10T1/2 cells synchronized with a pulse of dexamethasone,
inhibition of miR-433 using a tough decoy altered the period
and amplitude ofPer2 gene expression, suggesting thatmiR-433
regulates rhythm. Although miR-433 does not directly target
the Per2 3-UTR, it does target two rhythmically expressed
genes in calvaria, Igf1 andHif1. miR-433 can target the gluco-
corticoid receptor; however, glucocorticoid receptor protein
abundance was unaffected inmiR-433 decoy cells. Rather, miR-
433 inhibition dramatically enhanced glucocorticoid signaling
due to increased nuclear receptor translocation, activating glu-
cocorticoid receptor transcriptional targets. Last, in calvaria of
transgenicmice expressing amiR-433decoy in osteoblastic cells
(Col3.6 promoter), the amplitude of Per2 and Bmal1 mRNA
rhythmwas increased, confirming thatmiR-433 regulates circa-
dian rhythm. miR-433 was previously shown to target Runx2,
and mRNA for Runx2 and its downstream target, osteocalcin,
were also increased in miR-433 decoy mouse calvaria. We
hypothesize that miR-433 helps maintain circadian rhythm in
osteoblasts by regulating sensitivity to glucocorticoid receptor
signaling.
The circadian rhythm is an internal timing mechanism
important for orchestrating physiological homeostasis, through
synchronizing behavioral and physiological patterns. This
coordinates biological processes critical for overall health, such
as tissue repair and growth, maintenance of the immune
response, and optimization of metabolism. The circadian
rhythm is driven by a complex interaction between the hypo-
thalamic suprachiasmatic nucleus (SCN),4 also known as the
central clock, and the peripheral circadian clocks.As the central
oscillator, the SCN responds to environmental periodic cues,
such as light, eating patterns, and temperature. In response to
these cues, the SCN entrains peripheral circadian clocks
through stimulation of neural or hormonal signals (e.g. gluco-
corticoids) to enact their effects on target tissues (1).
In the central oscillator and peripheral tissues, the rhythm is
maintained locally by clock genes that interact through tran-
scriptional and post-transcriptional feedback loops. The main
positive regulators are aryl hydrocarbon receptor nuclear trans-
locator-like (Arntl or Bmal1) and circadian locomotor output
cycles kaput (Clock), which are negatively regulated by the
period genes (Per1,Per2, andPer3) and the cryptochrome genes
(Cry1 and Cry2), among others (for a review, see Ref. 2). Bmal1
and Clock form a heterodimer and bind to E-box elements of
target genes, including the Per and Cry genes, to rhythmically
induce transcription. PER/CRY can negatively feedback to
inhibit their own transcription as well as the transcription of
Bmal1/Clock, ensuring the anti-phasic expression of clock pro-
teins. This interaction between the clock proteins determines
the oscillatory expression of target genes and contributes to the
rhythmicity of physiological systems (3).
Bone is a continuously remodeling tissue, and disturbances
in circadian rhythm have a negative impact on skeletal health
(4–7). Bone remodeling is the coupled cycle of osteoclast-me-
diated bone resorption followed by osteoblast-mediated bone
formation. This process is critical for renewal of bone in adults
and for mineral homeostasis. Imbalance in the bone remodel-
ing process can lead to prevalent diseases, such as osteoporosis.
In osteoblasts, 26% of genes display a diurnal expression pat-
tern, including themaster osteoblast transcription factor Runt-
related transcriptional factor 2 (Runx2), bone morphogenetic
protein 2 (Bmp2), osteocalcin (Oc, Bglap), insulin-like growth
factor 1 (Igf1), and hypoxia-inducible factor 1 (Hif1) (4, 6).
Evidence suggests that, in humans, circadian rhythm coordi-
nates bone remodeling so that it occurs primarily at night. For
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example, bone formation markers, such as serum osteocalcin,
as well as serummarkers of type I collagen synthesis, the major
protein component of bone matrix, are highest in premeno-
pausal women at night (7, 8). Moreover, serum levels of gluco-
corticoids, which are known to play an important role in syn-
chronizing peripheral clocks, are critical for the diurnal
variation in serum osteocalcin (9).
MicroRNAs (miRNAs) are key mediators of post-transcrip-
tional regulation. These short (19–25-nucleotide) non-coding
RNAs bind specific target mRNAs, resulting in mRNA degra-
dation and/or translational suppression. Many miRNAs fine
tune the timing and tempo of gene expression programs, and
these post-transcriptional regulators are an important compo-
nent of circadian clock control. Indeed, miRNAs display circa-
dian rhythmicity inmany tissues, including the liver, retina, and
SCN (10, 11). miRNAs can directly regulate circadian clocks;
for example, miR-191 directly targets the 3-UTR of Bmal1 in
the liver (12). Alternatively, miRNAs can indirectly control cir-
cadian rhythm by targeting downstream regulators, as is the
case for miR-122 targeting of nocturnin, a key circadian dead-
enylase (13). Conversely, clock genes can directly regulate
miRNA expression; for example, BMAL1/CLOCK induces
expression ofmiR-219, and in vivomiR-219 knockdown results
in a lengthened circadian period (14).
miRNA regulation of circadian rhythm in the skeleton has
not been reported. However, within the adrenal gland,miR-433
was recently shown to target the glucocorticoid receptor (GR;
Nr3c1) 3-UTR (15). Rhythmic secretion of glucocorticoids is
critical for synchronizing local clocks in peripheral tissues, in
part by activating transcription of Per genes (16). Moreover, as
circulating glucocorticoid levels fluctuate diurnally, so does the
sensitivity of tissues to glucocorticoids (17). Herein, we demon-
strate that miR-433 regulates glucocorticoid signaling and
impacts the expression of the circadian clocks and osteoblastic
genes in vitro and in vivo.
Results
miR-433 Expression Is Rhythmic in Calvaria—To determine
whether miR-433 might play a role in osteoblast circadian
rhythm, we first determined whether it is under circadian reg-
ulation in the skeleton. RNA was isolated from calvaria of male
mice kept under a 12-h light/dark cycle, represented as Zeitge-
ber time (ZT). ZT0 is the beginning of light exposure, whereas
ZT12 is the beginning of light removal. Examining twomarkers
of circadian rhythm, Bmal1 and Per2, over two 24-h cycles,
these two circadian genes displayed the expected anti-phasic
pattern of expression throughout each 24-h cycle. For example,
Bmal1 mRNA expression was highest at ZT1, whereas Per2
mRNA was low; the nadir for Bmal1 mRNA was just before
light removal, whereas Per2mRNAhad its peak expression just
after dark (Fig. 1A).
We analyzed the expression of three microRNAs, miR-433,
miR-29a, and miR-30a, because they were either shown to dis-
play rhythmic expression in other tissues or were predicted via
bioinformatics analysis to potentially target the glucocorticoid
receptor or circadian clock genes (10). miR-433 displayed
robust rhythmicity in mouse calvaria (Fig. 1B). The miR-433
expression patternwas anti-phasic in relation toBmal1mRNA,
peaking at 4-fold after light removal and decreasing as night
progressed. miR-29a and miR-30a expression peaked at ZT17,
but the amplitude of their rhythmwasmoremodest in compar-
ison with miR-433 (Fig. 1B).
FIGURE 1. Rhythmic expression of circadian clock mRNAs, miRNAs and
osteogenicgenes inmousecalvariaandvalidationofan in vitromodel to
study circadian rhythm. C57BL/6J mice were kept under a 12-h light/dark
cycle; calvaria were harvested every 4 h. Two 24-h cycles are shown. RNA
levelswere quantified by quantitative RT-PCR. ZT0 indicates the beginning of
light exposure, and ZT12 indicates the beginning of light removal. A, markers
of circadian rhythm, Bmal1 (blue) and Per2 (red). B, miR-433 (red), miR-29a
(green), and miR-30a (black). C and D, osteogenic genes Runx2 (blue) and Igf1
(red) (C) and Hif1 (black) and Nr3c1 (glucocorticoid receptor) (green) (D).
-Fold change in each gene is expressed relative to the nadir (n 5). E, exper-
imental design for synchronizing C3H/10T1/2 cells and primary BMSCs. F–I,
expression of Bmal1 (blue) and Per2 (red) mRNA andmiR-433 in synchronized
C3H/10T1/2 cells (n  6) (F and G) and BMSCs (n  3) (H and I). Data are
expressed as -fold change in gene expression, relative to time 0. *, signifi-
cantly different from the nadir; p 0.05. Error bars, S.E.
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Wealso examined themRNAexpression of osteogenic genes
previously reported to display circadian rhythmicity in vivo (4,
5). Both Runx2 and Igf1 mRNAs appeared to peak early in the
day, whereasHif1mRNA displayed a broad peak during each
24-h cycle (Fig. 1,C andD). In contrast, glucocorticoid receptor
(Nr3c1) mRNA did not display rhythmic expression in calvaria
(Fig. 1D).
Development of an in Vitro Model to Study Circadian
Rhythm—Tobetter understand the role ofmiR-433 in circadian
rhythm, we used a well established protocol in which the mul-
tipotent mouse C3H/10T1/2 cell line and primary mouse bone
marrow stromal cells (BMSCs) were synchronized with a pulse
of the synthetic glucocorticoid dexamethasone (18, 19). Briefly,
C3H/10T1/2 cells and BMSCs were serum-deprived for 24 h
and then treated with a 2-h pulse of 100 nM dexamethasone.
The dexamethasone was removed (time 0) and replaced with
serum-freemedium, and RNAwas collected for up to 48 h (Fig.
1E). The C3H/10T1/2 cells remained synchronized for 48 h,
whereas the BMSCs only remained synchronized for 30 h.
Bmal1 and Per2 mRNA expression displayed rhythmic and
anti-phasic expression patterns in both C3H/10T1/2 cells and
BMSCs, confirming synchronization of the cultures (Fig. 1, F
andH). However, miR-433 did not display rhythmicity in either
cell type, suggesting that a systemic factor establishes miR-433
rhythm in vivo (Fig. 1, G and I).
miR-433 Targets the 3-UTR of Hif1 and Igf1 but Not Per2—
To determine whether miR-433 may directly target the circa-
dian clocks, we employed a bioinformatic approach using sev-
eral online databases (miRanda, TargetScan, and RNAhybrid)
to examine complementarity of the miR-433 seed binding
region to the 3-UTRof clockmRNAs (20–22).Of the circadian
clock genes, only Per2 contained a potential miR-433 binding
site at position 1829 (Fig. 2A). Runx2,Hif1, and Igf1 are rhyth-
mically expressed genes in bone. Whereas Runx2 was previ-
ously confirmed as amiR-433 target (23),Hif1 and Igf1 had yet
to be examined. The Hif1 3-UTR contained two potential
miR-433 binding sites at positions 352 and 879; the Igf1 3-UTR
contained two potential sites at 4237 and 6113 (Fig. 2A). To
determine whether Per2, Igf1, andHif1were miR-433 targets,
target gene 3-UTRs were cloned downstream of a constitu-
tively expressed luciferase gene in the reporter plasmid pMIR-
REPORT. The luciferase constructs containing the target
3-UTRswere transiently co-transfected intoC3H/10T1/2 cells
with a non-targeting ormiR-433 inhibitor, and luciferase activ-
ity was quantified. miR-433 inhibition significantly increased
the luciferase activity of Hif1 and Igf1 constructs compared
with the non-targeting control, but it did not affect Per2
3-UTR activity (Fig. 2B). These data suggest that miR-433
directly targets Igf1 and Hif1 but not Per2.
miR-433 Tough Decoy Suppresses miR-433 Activity—To bet-
ter study the impact of miR-433 on circadian rhythm, we devel-
oped a stably transducedC3H/10T1/2 cell line in which the activ-
ityofmiR-433couldbeknockeddowninan induciblemanner.We
used a previously described lentiviral knockdown (pSLIK) system
that allows for tight regulation of transgene expression via a doxy-
cycline (Dox)-inducible promoter (24). To achieve knockdown of
miR-433 activity, we created a miR-433 tough decoy, in which
a gfp (green fluorescent protein) reporter carries two miR-
433 binding sites in its 3-UTR (supplemental Fig. S1A and
Fig. 3A) (25). The miR-433 tough decoy contains a secondary
structure that enhances resistance to degradation. When
transcribed, the miR-433 tough decoy acts as a competitive
inhibitor for endogenous miR-433, therefore relieving sup-
pression of its targets. As a control, a C3H/10T1/2 cell line
was also established expressing a Dox-inducible non-target-
ing tough decoy construct.
To confirm doxycycline-inducible expression of the trans-
gene, we quantified GFP mRNA in the non-targeting and miR-
433 decoy cells treated for 24 h with increasing doses of Dox.
Dox induced gfp mRNA in both non-targeting and miR-433
decoy cells in a dose-dependent manner (Fig. 3B). To confirm
that the decoy inhibited miR-433 actions, we examined lucifer-
ase activity of the target 3-UTRconstructs thatwere previously
studied using the transiently transfected miR-433 inhibitor. In
these experiments, the miR-433 decoy phenocopied the effects
observed with transiently transfected miR-433 inhibitor, with
similar increases in luciferase activity with Igf1 and Hif1
3-UTR reporter constructs but no change with Per2 (Fig. 3C).
In miR-433 decoy cells, we also examined mRNA levels for a
previously definedmiR-433 targetRunx2 (23) aswell as Igf1 and
Hif1. Runx2, Igf1, and Hif1 mRNA levels were significantly
increased after a 24-h treatment with 1000 ng/ml Dox in the
miR-433 decoy cells but not in the non-targeting decoy cells
FIGURE 2. Examination of miR-433 targets. A, potential interaction of miR-
433withHif1, Igf1, andPer23-UTRs, as predictedbymiRanda (20).B, activity
of the Per2, Hif1, and Igf1 luciferase-3-UTR reporter constructs transiently
transfected into C3H/10T1/2 cells, along with a miR-433 or non-targeting
inhibitor. *, significantly different from non-targeting control; p 0.05 (n
12). Error bars, S.E.
miR-433 Regulates GR Signaling
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(Fig. 3, D–F). In contrast, Per2 mRNA was unaffected at any
dose tested (Fig. 3G). Analysis of miR-433 decoy cells at addi-
tional time points after Dox treatment also failed to demon-
strate significant differences in Per2 mRNA (data not shown),
confirming thatPer2 is not amiR-433 target.Overall, these data
demonstrate that the miR-433 decoy inhibits miR-433 activity.
Disruption ofmiR-433Activity Impacts the Rhythmicity of the
Circadian Clock—Although miR-433 did not display a cell-au-
tonomous rhythm in vitro, it is possible that this miRNA could
still play a role in maintenance or regulation of rhythm. To
examine this in vitro, non-targeting and miR-433 decoy cells
were synchronized with a short pulse of dexamethasone, in the
presence or absence of Dox. In the synchronized non-targeting
decoy cells, both Bmal1 and Per2 mRNA displayed two peaks
within the 48-h interval. Treatment of the non-targeting decoy
cells with Dox did not affect the rhythmicity of either Bmal1 or
Per2mRNA (Fig. 4, A and C). However, in cells expressing the
miR-433 decoy, the first peak inBmal1mRNAwas shifted from
6 to 12 h (Fig. 4B), and the amplitude of the peaks was
decreased. For Per2 mRNA, the effect of miR-433 inhibition
was more striking. In miR-433 decoy cells treated with Dox,
Per2 mRNA levels were significantly higher at time 0, and the
phase of the Per2 rhythmwas shifted (Fig. 4D). Like Bmal1, the
amplitude of Per2mRNA peaks was decreased in the presence
of the miR-433 decoy (Fig. 4D).
miR-433 Regulates Glucocorticoid Sensitivity—Glucocorti-
coids play a prominent role in synchronizing the peripheral
clocks, in part by activating transcription of Per genes (16).
Moreover, as circulating glucocorticoids levels fluctuate diur-
nally, so does the sensitivity of tissues to glucocorticoids.
Because miR-433 was previously shown by others to target the
glucocorticoid receptor 3-UTR (15) and because our cell cul-
tures were synchronized using dexamethasone, we hypothe-
sized that miR-433 could help maintain circadian rhythm in
cells of the osteoblastic lineage through regulation of glucocor-
ticoid signaling.
Dusp1 and Per2 are both direct transcriptional targets of the
glucocorticoid receptor, and we used their mRNA levels as
markers of glucocorticoid signaling (16, 26). In C3H/10T1/2
cells, dexamethasone induced Dusp1mRNA at 1–3 h, whereas
FIGURE 3.miR-433 decoy relieves repression of miR-433 target genes in
vitro. A, C3H/10T1/2 cells were stably transduced with a Dox-inducible con-
struct carrying either a non-targeting or miR-433 decoy in the 3-UTR of the
reporter gene GFP. The location of the miRNA binding site is denoted by the
heavy arrows. B, dose-dependent Dox-mediated induction of non-targeting
and miR-433 decoy in C3H/10T1/2 cells. C, activity of Per2, Hif1, and Igf1
luciferase-3 UTR reporter constructs transiently transfected into miR-433
decoy cells cultured in the presence or absence of Dox (n  12). D–F, dose-
dependentDox-mediated induction of Igf1 (D), Runx2 (E), andHif1 (F)mRNA
in miR-433 decoy cells, compared with non-targeting decoy cells (n 4). G,
Per2 mRNA was not induced by Dox treatment in either miR-433 or non-
targetingdecoy cells (n4). *, significantly different fromnoDox control;p
0.05. #, significantly different from non-targeting control; p 0.05. Error bars,
S.E.
FIGURE 4. Expression of themiR-433 decoy affects circadian clockmRNA
rhythmic expression.Non-targeting andmiR-433 decoy cells were cultured
in the absence or presence of 1000ng/ml doxycycline and then synchronized
using a 2-h pulse of 100 nM dexamethasone.mRNAwas isolated immediately
after the removal of dexamethasone (time 0) and at intervals up to 48h there-
after. Data are representedas relative expression innon-targeting (A andC) or
miR-433 (B and D) decoy cells. A and B, Bmal1; C and D, Per2. *, significantly
different from the corresponding time point with noDox treatment; p 0.05
(n 3). Error bars, S.E.
miR-433 Regulates GR Signaling
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the increase in Per2wasmore transient, peaking at 2 h (Fig. 5,A
and B). To determine whether miR-433 regulated the sensitiv-
ity of cells to glucocorticoids, we examined Dusp1 and Per2
mRNA in miR-433 decoy cells treated for 2 h with vehicle or
dexamethasone, in the absence or presence of Dox. In the
absence of miR-433 decoy, dexamethasone caused a modest
increase in Per2mRNA, independent of the dose used (Fig. 5C).
In contrast, expression of the miR-433 decoy augmented the in-
duction of Per2mRNA and caused a dose-responsive increase. In
the absence of miR-433 decoy, 10 or 100 nM dexamethasone
increased Dusp1 mRNA 6-fold (Fig. 5D). Expression of the
miR-433 decoy further enhanced Dusp1mRNA at both 10 and
100 nM dexamethasone (Fig. 5D). Because inhibition of miR-
433 activity allowed the cells to become responsive to higher
levels of glucocorticoids, it is possible thatmiR-433 functions to
limit exposure of cells to excessive glucocorticoid signaling.
We next examinedwhethermiR-433 could regulate the tem-
poral response to glucocorticoid signaling. miR-433 decoy cells
were treated with vehicle or 100 nM dexamethasone for up to
4 h, in the absence or presence of Dox, to induce expression of
the decoy. In the absence of Dox, dexamethasone increased
Per2 mRNA at 2 h of treatment (Fig. 5F). However, when the
miR-433 decoy was expressed, the dexamethasone-mediated
induction ofPer2mRNAwas accelerated such thatPer2mRNA
was significantly increased after only 1 h of treatment, and its
peak expression at 2 h was enhanced. Similarly, in the absence
of Dox, dexamethasonemodestly increasedDusp1mRNA after
1 h of treatment in miR-433 decoy cells (Fig. 5H). However,
expression of the miR-433 decoy significantly enhancedDusp1
mRNA levels at 1–3 h of treatment with dexamethasone. In
contrast, in non-targeting decoy cells, the effects of dexameth-
asone on Per2 and Dusp1mRNAs were similar in the presence
or absence of Dox (Fig. 5, E and G). These data confirm that
miR-433 confines glucocorticoid responsiveness.
To determine howmiR-433might regulate sensitivity to glu-
cocorticoid signaling, we first examined the impact of the miR-
433 decoy on glucocorticoid receptor mRNA (Nr3c1) and pro-
tein levels. To mimic the conditions of the circadian
synchronization experiments, we performed these studies in
cells cultured for 24 h in the presence or absence of Dox and
then treatedwith 100 nM dexamethasone for 2 h. In non-target-
ing decoy cells, culture in the presence or absence of Dox did
not affect mRNA or protein levels ofNr3c1 (Fig. 6, A andD). In
contrast, miR-433 decoy cells treated with Dox displayed a
3-fold induction of Nr3c1 mRNA (Fig. 6A). However, signifi-
cant differences in total GR protein levels were not observed at
any time point measured (Fig. 6D). It is possible that inhibition
of miR-433 alters GR mRNA translation efficiency, perhaps by
indirectly modifying the complement of miRNAs or RNA-
binding proteins interacting with the transcript. GR protein
stability could also be affected because GR is subject to ubiqui-
tin-mediated degradation. Overall, these data suggest that an
increase in total glucocorticoid receptor levels was not respon-
sible for the increased sensitivity to dexamethasone.
Alternative forms of themouse glucocorticoid receptor,GR
or GR, are generated by alternative splicing (27). It was
reported previously that GR acts as a transcriptional activator
of glucocorticoid signaling, whereas GR can act as a dominant
negative inhibitor ofGR (27–29). Because commercially avail-
able antibodies for the mouse glucocorticoid receptor do not
discriminate betweenGR andGR isoforms, we relied on iso-
form-specific quantitative RT-PCR to determine whethermiR-
433 inhibitionmight cause differences in the expression ofGR
versus GR mRNA. miR-433 decoy cells were cultured in the
absence or presence of Dox for 24 h and then treated with or
without dexamethasone for 2 h. GR mRNA was increased in
miR-433 decoy cells cultured in Dox, and treatment with dex-
amethasone did not alter GR mRNA levels (Fig. 6B). GR
mRNA levels were also increased inDox-treated cells; however,
FIGURE 5.miR-433dampens sensitivity toglucocorticoid signaling.A and
B, Per2 (A) and Dusp1 mRNA (B) in serum-deprived C3H/10T1/2 cells treated
with vehicle or 100 nM dexamethasone for up to 3 h. C and D, Per2 (C) and
Dusp1 mRNA levels (D) in miR-433 decoy cells that were serum-deprived in
the presence or absence of Dox and then treated with increasing doses of
dexamethasone for 2 h. E–H, Per2 (E and F) and Dusp1 (G and H) mRNA levels
in non-targeting decoy (E and G) or miR-433 decoy (F and H) cells that were
serum-deprived in the presence or absence of Dox and then treated with
vehicleor 100nMdexamethasone for up to4h (n8). *, significantlydifferent
from corresponding no Dox control; p  0.05. #, significantly different from
corresponding vehicle-treated control; p 0.05. Error bars, S.E.
miR-433 Regulates GR Signaling
OCTOBER 7, 2016•VOLUME 291•NUMBER 41 JOURNAL OF BIOLOGICAL CHEMISTRY 21721
 at U
niversity of A
berdeen on N
ovem
ber 24, 2016
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
dexamethasone decreased GR mRNA levels by about 50%,
whether the miR-433 decoy was expressed or not (Fig. 6C).
These data suggest that although dexamethasone affects the
mRNAratio ofGR toGR, inhibition ofmiR-433 activity does
not impact this ratio.
Because the miR-433 decoy increased glucocorticoid signal-
ing in the absence of significant increases inGRprotein levels or
changes in receptor isoformmRNA,wenext examinedwhether
miR-433 levels might affect the nuclear versus cytosolic local-
ization of the GR. In the absence of ligand, GR is localized pri-
marily in the cytoplasm, in a complex that includes heat shock
protein 90, immunophilins, and non-receptor tyrosine kinases
(30). Upon ligand binding to the GR, this complex is dissoci-
ated, and GR dimers translocate to the nucleus to elicit tran-
scriptional regulation of target genes. We hypothesized that
miR-433 inhibition might increase nuclear GR with glucocor-
ticoid stimulation. To test this, miR-433 decoy cells were cul-
tured in the presence or absence of Dox for 24 h and then
treatedwith orwithout dexamethasone for 2 h. The levels ofGR
in nuclear and cytoplasmic compartments were evaluated by
Western blotting. In the absence of dexamethasone, themajor-
ity of glucocorticoid receptor was found in the cytoplasm, and
expression of the miR-433 decoy did not significantly alter its
abundance. As expected, when cells were treated with dexam-
ethasone, the abundance of GR in the cytoplasm was dramati-
cally decreased; this decrease was also not significantly affected
by expression of the miR-433 decoy (Fig. 6E). Examining the
nuclear compartment, in the absence of dexamethasone stim-
ulation, GR levels were similar in cells with or without themiR-
433 decoy. However, in cells treatedwith dexamethasone, there
was an increase in nuclear GR levels, which was significantly
enhanced by expression of the miR-433 decoy (Fig. 6F). The
enhanced translocation and possiblymaintenance of the gluco-
corticoid receptor to the nucleus upon ligand binding provides
a potential mechanism for the enhanced responsiveness of
miR-433 decoy cells to dexamethasone.
Heat shock protein 90 (HSP90) plays an important chaper-
one function for GR in both the cytoplasm and nucleus. Hyper-
FIGURE6.miR-433 regulatesglucocorticoid receptormRNAandsubcellular localization.Non-targeting andmiR-433decoy cellswere serum-deprived for
24 h in the presence or absence of Dox and then treated with 100 nM dexamethasone for 2 h. Total glucocorticoid receptor mRNA (A) and glucocorticoid
receptor mRNA isoforms GR (B) and GR (C) were quantified (n 8).D, miR-433 decoy cells were serum-deprived in the presence or absence of Dox for 24 h
and then treated with 100 nM dexamethasone for 2, 3, 6, or 24 h. Total glucocorticoid receptor protein levels were determined byWestern blotting (represen-
tative blot from a 2-h treatment, above) and were quantified (below) (n 4). miR-433 decoy cells were serum-deprived for 24 h in the presence or absence of
Doxand then treated for 2hwith 100nMdexamethasone.Glucocorticoid receptor subcellular localizationwasdeterminedbyWesternblotting (representative
blot, above) andwere quantified (below): cytoplasmic (E) and nuclear (F) extracts (n 10). miR-433 decoy cells were serum-deprived for 24 h in the absence or
presence of Dox, and Hdac6 mRNA (G) and protein (H) were quantified (n  7). *, significantly different from corresponding no Dox control; p  0.05. #,
significantly different from corresponding vehicle-treated control; p 0.05. Error bars, S.E.
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acetylation ofHSP90 results in loss of its GR chaperone activity,
causing defects inGR ligandbinding, nuclear translocation, and
transcriptional activation (31, 32). Histone deacetylase 6
(HDAC6) can deacetylate HSP90, and in humans, miR-433 has
been shown to target Hdac6 (32). Should the miR-433 decoy
increase expression of Hdac6, it could represent a potential
mechanism for increasing GR nuclear localization. In miR-433
decoy cells cultured in the presence of Dox, Hdac6 mRNA
expression and protein levels were significantly increased (Fig.
6, G and H), indicating that miR-433 targets Hdac6 in mice as
well as humans. miR-433 effects on Hdac6 could contribute to
its regulation of glucocorticoid sensitivity.
Glucocorticoids Down-regulate miR-433—Because microRNAs
often participate in feedback loops, we determined whether
glucocorticoids might regulate the expression of miR-433. In
serum-deprived C3H/10T1/2 cells treated with 100 nM dexam-
ethasone for up to 24 h, we found a modest (20–25%) but sig-
nificant reduction of miR-433 only at the 24 h time point
(Fig. 7A). Serum-deprived confluent cultures of primary
BMSCs displayed a similar decrease in miR-433 expression
with dexamethasone treatment (Fig. 7B). This delay in response
suggests that dexamethasone may indirectly regulate miR-433
expression, or it could reflect the generally high stability of
many miRNAs.
miR-433 Regulates Circadian Clocks and Osteoblastic Genes
in Vivo—Our in vitro studies indicated that miR-433 activity
dampens glucocorticoid signaling and is important for main-
taining rhythmic gene expression in osteoblastic cells. To
determine whether miR-433 plays a similar role in the regula-
tion of the circadian clocks in vivo, we developed a transgenic
mouse model in which the miR-433 decoy, contained within
the 3-UTR of the red fluorescent reporter gene tdTomato, was
expressed under the control of a 3.6-kb fragment of the rat
Col1a1 promoter (miR-433 decoyCol1a1 mice) (Fig. 8 and
supplemental Fig. S1C). Previous studies document that trans-
genes under the control of this promoter are expressed most
abundantly in osteoblastic cells, with lesser expression in other
type I collagen-containing tissues (33, 34). Fluorescence
microscopy of calvarial sections from miR-433 decoyCol1a1
mice demonstrated that signal for tdTomato was localized to
osteocytes embedded in the bone matrix and cells on the peri-
osteal and endosteal surfaces, where new bone is formed (Fig.
8A).
To determine the impact of miR-433 on circadian rhythm,
RNA was isolated from calvaria of 8-week-old male miR-433
decoyCol1a1 mice and matched litter mate controls euthanized
every 6 h over an 18-h period. Bmal1 and Per2mRNA expres-
sion showed rhythmic and anti-phasic expression in both wild
type and miR-433 decoyCol1a1 mice (Fig. 8, B and C). However,
FIGURE 7. Dexamethasone decreases miR-433 expression.miR-433 levels
in serum-deprived C3H/10T1/2 cells (A) or mouse bone marrow stromal cells
(B) treated with vehicle or 100 nM dexamethasone for up to 24 h. #, signifi-
cantly different from vehicle control; p 0.05 (n 8). Error bars, S.E.
FIGURE 8.miR-433 regulation of circadian clocks and osteoblast genes in
vivo. Calvaria were isolated from male transgenic mice expressing the miR-
433decoy under the control of aCol1a1promoter (miR-433decoyCol1a1mice)
and wild type littermate controls. A, schematic of Col3.6/1.6_tdTomato_miR-
433 decoy transgene cassette. A 3.6-kb fragment of the rat Col1a1 gene plus
the first intron drive expression of the reporter gene tdTomato and a 3-UTR
containing three copies of amiR-433 tough decoy (miR-433 binding sites are
denoted by black arrows), a woodchuck hepatitis virus posttranscriptional
regulatory element (WPRE), and bovine growth hormone polyadenylation
signal (polyA). Shown is an example of td Tomato transgene and DAPI fluo-
rescence in a calvarium from a 4-week-old male miR-433 decoyCol1a1 mouse
at ZT13. B and C, mRNA levels from calvaria of 8-week-old mice for Bmal1 (B)
and Per2 (C) at ZT1, ZT7, ZT13, and ZT19. Runx2 andDusp1 (D) and osteocalcin
(Oc) and Igf1 (E) mRNAwere quantified in calvaria at ZT13. Shown are pooled
data from two miR-433 decoyCol1a1 lines having a similar level of transgene
expression. n 7 for WT; n 8 for miR-433 decoyCol1a1. *, significantly differ-
ent WT littermates; p 0.05. Error bars, S.E.
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the amplitude of Bmal1mRNA rhythm inmiR-433 decoyCol1a1
mice was significantly increased comparedwith littermate con-
trols (Fig. 8B). The amplitude of Per2 mRNA rhythm was also
significantly increased in miR-433 decoyCol1a1 mice (Fig. 8C).
Thus, miR-433 dampens the rhythm of circadian clock genes in
vivo, supporting its role in the regulation of circadian rhythm.
miR-433 can directly targetRunx2 and Igf1, suggesting that it
may negatively regulate osteoblastogenesis (23). Indeed, cal-
varia frommiR-433 decoyCol1a1 mice had 1.5-fold higher levels
of Runx2 mRNA as well as elevated mRNA for the RUNX2
target gene, osteocalcin (Fig. 8, D and E). Expression of the
glucocorticoid-responsive gene Dusp1 was also increased
2-fold in bone from miR-433 decoyCol1a1 mice (Fig. 8D). In
contrast, Igf1 mRNA was similar in wild type and miR-433
decoyCol1a1 mice (Fig. 8E). Overall, inhibition of miR-433 activ-
ity increased the expression of glucocorticoid-responsive genes
and increased expression of a subset of osteoblast marker genes
in vivo, supporting in vitro observations.
Discussion
The circadian clocks are crucial regulators of organismal
physiology and behavior, operating through a series of positive
and negative feedback loops, the regulation of which includes
microRNAs. In this study, we demonstrate that miR-433 dis-
plays a robust rhythmic expression in the calvaria and thatmiR-
433 is important in maintaining the rhythmic expression of the
circadian clocks in vitro and in vivo. miR-433 serves to limit the
responsiveness of mesenchymal cells to glucocorticoids, which
could contribute to its regulation of circadian rhythm. In addi-
tion, we identified two novel targets ofmiR-433, Igf1 andHif1,
both of which display rhythmicity in vivo and play an important
role in osteogenesis. Altogether, we showed that miR-433 can
modify responsiveness of cells to glucocorticoids, providing a
potential mechanism contributing to its ability to regulate
rhythmic gene expression in bone and possibly other tissues.
Although microRNAs were shown to be important regula-
tors of circadian rhythm in non-skeletal tissues (11, 12, 14), to
our knowledge, this is the first study examining the role ofmiR-
NAs in circadian rhythm in bone. In our study, miR-433 dis-
played a sizeable rhythmicity in the calvaria, and its rhythmhad
a larger amplitude compared with miR-29a and miR-30a, two
microRNAs previously shown to display significant rhythmic-
ity in the liver (10). It is likely that other miRNAs display circa-
dian rhythm in the calvaria, and this remains to be examined.
miRNAs can regulate circadian rhythm through direct tar-
geting of the circadian clocks, by regulation of entrainment, or
by reducing target mRNAs’ oscillation amplitude or frequency
(35). Several miRNAs have been found to impact circadian
rhythms in the liver, with miR-122 being the most studied. The
miR-122 locus is under the direct regulation of REV-ERB, an
important circadian protein that functions by recruiting his-
tone deacetylases (HDACs), repressing gene expression (36).
Systemic administration ofmiR-122 antisense oligonucleotides
caused substantial alterations in amplitude, magnitude, and
phase of several rhythmicmRNAs in the liver, with correspond-
ing changes in expression of genes involved in cholesterol and
lipid metabolism (36). Whereas previous studies examined the
direct regulation of miRNAs on the circadian clocks, our study
suggests that miR-433 regulation of glucocorticoid signaling in
peripheral tissues could impact the rhythmic expression of the
circadian clocks in vivo (i.e. synchrony).
Glucocorticoids, among other hormones, are important
entrainment signals that synchronize circadian rhythms in the
kidney, liver, heart, and other tissues (37). High levels of gluco-
corticoids can disrupt circadian rhythm (38). In humans, serum
levels of glucocorticoids cycle, with their peak in the early
morning, just before waking, and their lowest levels in the eve-
ning (39). The circadian clocks can be directly regulated by
glucocorticoid signaling, as the glucocorticoid receptor tran-
scriptionally activates expression of Per1 through a glucocorti-
coid response element (GRE) in its promoter and Per2 through
aGRE in the first intron (16, 40, 41). Indeed, oscillating levels of
circulating glucocorticoids correspond to Per1 levels in periph-
eral tissues (42).
Glucocorticoid receptor-induced transcriptional activity can
also be directly suppressed by CLOCK, which assists with
acetylating the GR hinge domain (17, 43). This acetylation
attenuates the binding of theGR toGREs, limiting its actions. In
peripheral tissues, the BMAL1/CLOCK-mediated counter-
regulation of glucocorticoid signaling provides a mechanism to
prevent overexposure of target tissues to glucocorticoids at
times when serum levels of glucocorticoid are at their peak (1).
Similarly, we demonstrate that miR-433 activity blunts gluco-
corticoid signaling. In mice, miR-433 levels peak just after dark
(Fig. 1), and serumglucocorticoids peak just before dark (44). In
calvaria of miR-433 decoyCol1a1 mice, we observed increased
mRNA for the glucocorticoid receptor target genes Per2 and
Dusp1 (Fig. 8), further supporting the concept that miR-433
serves as an additional mechanism to limit exposure of osteo-
blastic cells to glucocorticoids in vivo.
In humans, miR-433 has been shown to target the HDAC6
3-UTR (32), and we showed that inhibition of miR-433
enhanced Hdac6 mRNA and protein. miR-433 could regulate
the acetylation status of HDAC6 targets, including the gluco-
corticoid receptor or its chaperone HSP90, as well as many
other targets. As discussed previously, hyperacetylation of
HSP90 compromises its GR chaperone activity, causing defects
inGR ligand binding, nuclear translocation, and transcriptional
activation (31, 32). Our results indicate that miR-433 can regu-
late the sensitivity of cells to glucocorticoids through decreas-
ing translocation of the GR to the nucleus. It is possible that
miR-433 controls HSP90 acetylation and chaperone function
by targeting Hdac6, fine tuning glucocorticoid responsiveness.
The role of glucocorticoid signaling in bone is complex. Nor-
mal, endogenous glucocorticoids are critical for skeletal health
(for a review, see Ref. 45). Glucocorticoids can enhance the
expression of osteoblast differentiation markers, such as alka-
line phosphatase, osteocalcin, and bone sialoprotein, in vitro
(for a review, see Ref. 46). In contrast, excessive exposure of the
skeleton to glucocorticoids leads to the development of osteo-
porosis, which is frequently seen in patients treated long term
with glucocorticoids for autoimmune disorders, inflammatory
disease, or malignancy. Glucocorticoid excess causes bone loss
due to decreased osteoblast activity, reduced osteoblast num-
ber, increased osteocyte apoptosis, and disruption of extracel-
lular matrix production (for a review, see Ref. 47). In our in vivo
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model, calvaria from mice expressing the miR-433 decoy in
osteoblastic cells had increasedmRNA forRunx2 and its down-
stream target, osteocalcin. This was not unexpected, because
miR-433 was previously shown to target Runx2 (23). That Igf1
was not similarly increased suggests that other mechanisms,
transcriptional or post-transcriptional, predominate in the reg-
ulation of this gene in vivo. We are in the process of fully char-
acterizing the skeletal phenotype of miR-433 decoyCol1a1 mice
to better understand the function of miR-433 in bone.
We identified two new miR-433 targets, Hif1 and Igf1,
which have been shown to be to be important factors in bone
formation and homeostasis (48–51). IGF1 enhances osteoblast
differentiation and induces osteoblast proliferation (50). HIF1
is important in coupling angiogenic and osteogenic activity, to
promote bone formation (49, 51). In calvaria,miR-433 levels are
highest whenmRNA levels of its targets,Runx2 and Igf1, are the
lowest. In contrast, the peak of miR-433 coincides with a broad
peak in Hif1mRNA. It is possible that miR-433 serves to fine
tune expression of this regulator.
Transcription of the miR-433 locus has been shown to be
induced by orphan receptor estrogen-related receptor 
(ERR), a negative regulator of osteogenesis, whereas its tran-
scription can be repressed by small heterodimer partner (SHP),
which promotes osteoblast differentiation (23, 52, 53).
Although estrogen-related receptors have been linked to
energy homeostasis and can display circadian regulation, it is
not knownwhether thesemechanisms are active in calvaria (54,
55). Disruption of normal circadian rhythm, resulting in
changes of clock amplitude, period length, or frequency, lead to
alterations in chromatin modification, gene regulation, cellular
metabolism, and immune responses (56). Consequently, chronic
desynchrony is associated with the development and progression
of cardiovascular disease, cancer,mental illnesses, and severemet-
abolic disorders (for a review, see Ref. 57).
Overall, we found that miR-433 displays rhythmicity in cal-
varia, regulates cell sensitivity to glucocorticoids, and helps
maintain rhythmic gene expression. Because miR-433 levels in
bone peak when circulating glucocorticoid levels are high, it
probably plays a role in balancing the glucocorticoid response.
We speculate that miR-433 can modify the responsiveness of
peripheral tissues to variations in circulating glucocorticoids
and alter bone metabolism. miR-433 also targets Hdac6, pro-
viding a mechanism for modulating the acetylation status of
multiple HDAC6 targets. These findings provide an added
dimension to our understanding of the mechanisms regulating
glucocorticoid responsiveness, circadian rhythm, and their
potential impact on the skeleton and possibly other tissues.
Experimental Procedures
Mice—C57BL/6malemice were kept under a 12-h light/dark
cycle and providedwith food andwater ad libitum. Eight-week-
old male mice were euthanized every 4 h, and calvaria were
collected.
We created mice expressing a transgene in which a 3.6-kb
fragment of the rat Col1A1 promoter, plus 1.6 kb of the first
intron drive expression of the tdTomato reporter gene carrying
a miR-433 tough decoy in its 3-UTR (custom synthesis, Gen-
Script, Piscataway, NJ) (Fig. 8A and supplemental Fig. S1C) (25,
33).Micewere generated in aC57BL/6 backgroundby pronuclear
injectionof the transgene cassette at theUConnHealthGeneTar-
geting and Transgenic Facility. The miR-433 decoy serves as a
competitive inhibitor of miR-433 activity, relieving the suppres-
sionof endogenousmiR-433 targets.The sequenceof themiR-433
tough decoy is provided in supplemental Fig. S1C. Eight-week-old
male transgenic mice and wild type littermates were euthanized
every 6 h, and calvaria were collected.
All animal protocols were reviewed and approved by the
UConn Health institutional animal care and use committee.
Cell Culture and Synchronization—C3H/10T1/2, clone 8, a
multipotent mouse mesenchymal cell line, was obtained from
the American Type Culture Collection (ATCC, CCL-226) and
cultured in DMEM (Gibco) supplemented with 10% heat-inac-
tivated FBS (Lonza, Basel, Switzerland). Primary BMSCs were
flushed from the long bones of 6–8-week-old male C57BL/6
mice and maintained in DMEM supplemented with 10% FBS.
Cells were synchronized by 24 h of serum deprivation, followed
by treatment for 2 h with 100 nM dexamethasone (Sigma-Al-
drich). The dexamethasone was then replaced with serum-free
medium for the remainder of the experiment (19). Amplitude
was determined by calculating the difference between a peak
and the mean value of the wave.
Quantitative Real-time PCR—Total RNA from calvaria sam-
ples was extracted using the miRNeasy minikit (Qiagen, Valen-
cia, CA). Calvaria were homogenized in Qiazol. RNA was iso-
lated from cell cultures using TRIzol reagent (Life
Technologies, Inc.). RNA samples were DNased using RQ1
DNase (Promega, Madison, WI). DNased RNA was reverse-
transcribed using Moloney murine leukemia virus-reverse
transcriptase (Invitrogen). Gene expression was quantified by
quantitative PCRwith iQ SYBRGreen Supermix (Bio-Rad) and
normalized to 18S rRNA. Primer sets are shown in supplemen-
tal Table S1. MicroRNA expression levels were analyzed using
the TaqMan microRNA assay (Life Technologies). RNA was
reverse transcribed with gene-specific primers to generate
cDNA. MicroRNA expression was detected by quantitative
PCR and normalized to snoRNA 202. Each sample was assayed
in duplicate.
Luciferase Assay—Gene-specific PCR primers were used to
amplify from genomic DNA template the 3-UTR for Igf1
(mouse, bp 1–6217),HIF1 (human, bp 2612–3906), and PER2
(human, bp 866–2041). These fragments were subcloned
downstream of a cytomegalovirus promoter-driven luciferase
reporter (pMIR-REPORTvector, Ambion,Carlsbad, CA). Con-
structs were verified by sequencing.
C3H/10T11/2 cells were plated at 25,000 cells/cm2. BioT
transfection reagent (1.5l per 1g ofDNA; Bioland Scientific,
Paramount, CA) was used to co-transfect luciferase constructs
containing the 3-UTR of target mRNA, a constitutively active
-galactosidase construct (control for transfection efficiency),
and miRNA hairpin inhibitors (Dharmacon/Thermo Fisher
Scientific, Waltham, MA). 80 nM miR-433 or negative control
(non-targeting) miRNA inhibitors were used. Cell lysates were
analyzed for luciferase activity using the Luciferase assay sys-
tem (Promega) and normalized to -galactosidase using Galac-
ton (Life Technologies). More than one preparation of each
DNA construct was tested.
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Establishment of a Stable Inducible miR-433 Knockdown
Model—To achieve knockdown of miR-433 activity, C3H/
10T11/2 cells were transduced using lentiviral constructs con-
taining a miR-433 tough decoy (custom synthesis, GenScript)
driven by a Dox-inducible promoter. The miR-433 decoy con-
tains complementary sites that will bind endogenous miR-433.
The miR-433 decoy was subcloned into the single lentivector
for inducible knockdown (pSLIK) system and confirmed by
sequencing (24) (Addgene, Cambridge, MA). Doxycycline
treatment stimulates the decoy. As a control, we developed a
non-targeting tough decoy containing Caenorhabditis elegans
miR-67 binding sites (custom synthesis, GenScript), which is
not predicted to interact with mammalian miRNAs. Pools of
cells stably transduced with the pSLIK-miR-433 decoy or non-
targeting decoy were selected for hygromycin resistance. The
sequence for the miR-433 and non-targeting decoy may be
found in supplemental Fig. S1, A and B.
Western Blotting—C3H/10T1/2 cells were plated at 200,000
cells/cm2 and treated with doxycyline for 24 h in serum-free
medium to induce expression of the decoy. Cells were lysed
with radioimmune precipitation buffer containing HaltTM pro-
tease inhibitors (Thermo Fisher Scientific). A BCA assay
(Thermo Fisher Scientific) was performed to quantify protein,
and 20 g of protein was subjected to electrophoresis on a 10%
SDS-polyacrylamide gel. Proteins were transferred to a PVDF
membrane (Millipore, Billerica,MA). Rabbit anti-mouse gluco-
corticoid receptor primary antibody (1:1000; Cell Signaling
(Danvers, MA), D6H2L), rabbit anti-HDAC6 antibody (1:1000;
Cell Signaling, D21B10), rabbit anti--actin antibody (1:2000;
Cell Signaling, 13E5), and goat anti-rabbit horseradish peroxi-
dase-conjugated antibody (1:10,000; Sigma-Aldrich, A0545)
were used.
To analyze nuclear versus cytosolic localization of the gluco-
corticoid receptor, C3H/10T1/2 cells were serum-deprived for
24 h, in the presence or absence of doxycycline, and then
treated with or without 100 nM dexamethasone for 2 h. Cells
were trypsinized and pelleted. Pellets were suspended in a cyto-
solic extraction buffer (10 mMHepes, 60 mM KCl, 1 mM EDTA,
0.075% Igepal 40, 1 mM DTT, and 1 mM PMSF). The lysate was
pelleted, and the supernatant was collected as the cytosolic
fraction. Pellets were resuspended in nuclear extraction buffer
(20 mM Tris-Cl, 420 mMNaCl, 1.5 mMMgCl2, 0.2 mM EDTA, 1
mMPMSF, and 25%glycerol) and thenpelleted; the supernatant
was collected as the nuclear fraction. Half of each lysate was
subjected to electrophoresis on a 10% SDS-polyacrylamide gel
and transferred to PVDF membrane, and the same antibody
dilutions as noted above were used for the glucocorticoid
receptor and -actin. For the nuclear fraction, rabbit anti-
mouse proliferating cell nuclear antigen was used to control for
loading (1:2000; Cell Signaling, 13110P). Chemiluminescent
signal was achieved using SuperSignal West Pico Kit (Thermo
Fisher Scientific) and captured using the Bio-Rad ChemiDoc
XRS imaging system.Densitometry of protein bandswas per-
formed using ImageJ analysis (58). Levels of the glucocorticoid
receptor were normalized to either -actin or proliferating cell
nuclear antigen.
Cryohistology and Microscopy Imaging—Calvaria from
4-week-old male mice were fixed (4% paraformaldehyde),
decalcified (14% EDTA-acid, 0.9% ammonium hydroxide), and
washed in a 30% sucrose PBS solution at 4 °C. Samples were
embedded inO.C.T. compound (VWR,Radnor, PA). 7-msec-
tionswere collectedwith aCryofilm type II tape transfer system
(Section Lab Co. Ltd., Hiroshima, Japan). Sections were
mounted for imaging (50% glycerol buffered with PBS contain-
ing 0.2 mg/ml DAPI; Thermo Scientific Fisher), imaged with a
Zeiss Observer Z.1 microscope, and captured using an
AxiocamMRc digital camera and Axiovision software (Zeiss).
Statistics—All data are represented as mean S.E. Statistical
significance was determined using two-tailed analysis of vari-
ance with Bonferroni post hoc test or Student’s t test as appro-
priate (KaleidaGraph, Synergy Software, Reading, PA).
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S1 
 
Supplemental Materials 
 
A. 
 
GACGGCGCTAGGATCATCAACACACCGAGGAGCCTAACCATCATGATCAAGTATTCTGGTC
ACAGAATACAACACACCGAGGAGCCTAACCATCATGATCAAGATGATCCTAGCGCCGTCC
GA 
 
B. 
 
GATATCGACGGCGCTAGGATCATCAACTCTACTCTTTCTAGAGCTGAGGTTGTGACAAGTA
TTCTGGTCACAGAATACAACTCTACTCTTTCTAGAGCTGAGGTTGTGACAAGATGATCCTAG
CGCCGTCATCGAT 
 
C. 
 
GACGGCGCTAGGATCATCAACACACCGAGGAGCCTAACCATCATGATCAAGTATTCTGGTC
ACAGAATACAACACACCGAGGAGCCTAACCATCATGATCAAGATGATCCTAGCGCCGTCCa
ggttgttccaatgccaatctgtaaatacgagattcttaacgggttcaattcgcaactattggacaacaacacaaatggaccGACGG
CGCTAGGATCATCAACACACCGAGGAGCCTAACCATCATGATCAAGTATTCTGGTCACAGA
ATACAACACACCGAGGAGCCTAACCATCATGATCAAGATGATCCTAGCGCCGTCGGCCGG
CCGTCGACCTGCAGTtttgaagaagagatccgctccagtaatggagaatattcttgatgtGACGGCGCTAGGATC
ATCAACACACCGAGGAGCCTAACCATCATGATCAAGTATTCTGGTCACAGAATACAACACA
CCGAGGAGCCTAACCATCATGATCAAGATGATCCTAGCGCCGTCCGA 
 
Supplemental Figure 1. Sequence of miR-433 decoy and non-targeting decoys used in 
vitro and in vivo. 
(A) miR-433 tough decoy used in vitro, with miR-433 binding sites underlined (GenScript custom 
synthesis) 
(B) Non-targeting tough decoy used in vitro. It contains C. elegans miR-67 binding sites, which 
are underlined (GenScript custom synthesis) 
(C) Sequence of miR-433 decoy used for transgenic mouse:  Three miR-433 tough decoys were 
assembled. DNA from the coding region of the C. elegans Cut3 gene was used as spacer 
between the repeats of miR-433 decoy, and is denoted by lower case letters. The miR-433 
binding sites are underlined. The fragment was custom synthesized by GenScript.  
 
 
  
 
 
 
 
  
S2 
 
 
 
Supplemental Table 1:  Primer sequences used for qPCR analysis.   
Gene (mouse) Sequence 
18S (sense) 
18S (antisense) 
5’-GCGTGTGCCTACCCTACGCC -3’ 
5’-ACGCAAGCTTATGGCCCGCA-3’ 
Bmal1 (sense) 
Bmal1 (antisense) 
5’-AACCTTCCCGCAGCTAACAG -3’ 
5’-AGTCCTCTTTGGGCCACCTT -3’ 
Per2 (sense) 
Per2 (antisense) 
5’-AGAACGCGGATATGTTTGCTG-3’ 
5’-ATCTAAGCCGCTGCACACACT-3’ 
Hif1α (sense) 
Hif1α (antisense) 
5′-ACCTTCATCGGAAACTCCAAAG -3′  
5′-ACTGTTAGGCTCAGGTGAACT-3′ 
Nr3c1 (sense) 
Nr3c1 (antisense) 
5′-GTGAGTTCTCCTCCGTCCAG -3′  
5′-TGCAATCATTTCTTCCAGCA-3′ 
Runx2 (sense) 
Runx2 (antisense) 
5′-CCTCTGGCCTTCCTCTCTCAGT -3′  
5′-GCCACTCTGGCTTTGGGAAGAG -3′ 
Igf1(sense) 
Igf1 (antisense) 
5′-CACACTGACATGCCCAAGAC -3′  
5′-GGGAGGCTCCTCCTACATTC -3′ 
GFP (sense) 
GFP (antisense) 
5′-GTGAGCAAGGGCGAGGAGCTGTTC -3′  
5′-GTAGGTCAGGGTGGTCACGAGGG -3′ 
GRα (sense) 
GRα (antisense) 
5′-AAAGAGCTAGGAAAAGCCCATTGTC-3′  
5′-TCAGCTAACATCTCTGGGAATTCA -3′ 
GRβ (sense) 
GRβ (antisense) 
5′-AAAGAGCTAGGAAAAGCCCATTGTC-3′  
5′-CTGTCTTTGGGCTTTTGAGATAGG -3′ 
Dusp1 (sense) 
Dusp1 (antisense) 
5′-CAGCTGCTGCAGTTTGAGTC -3′  
5′-GGGATGGAAACAGGGAAGTT -3′ 
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